Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Liposome Drug Delivery Market by Type (Liposomal Doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel, Others), By Application (Cancer & Tumor Therapy, Fungal Infection Therapy, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Liposome Drug Delivery Market by Type (Liposomal Doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel, Others), By Application (Cancer & Tumor Therapy, Fungal Infection Therapy, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 137771 3300 Pharma & Healthcare 377 231 Pages 4.9 (36)
                                          

Industry Growth Insights published a new data on “Liposome Drug Delivery Market”. The research report is titled “Liposome Drug Delivery Market research by Types (Liposomal Doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel, Others), By Applications (Cancer & Tumor Therapy, Fungal Infection Therapy, Others), By Players/Companies Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma, Sigma-Tau Group, Fudan-Zhangjiang, Teva Pharmaceutical, CSPC, Novartis, Kingond Pharm, Spectrum Pharmaceuticals, Shanghai New Asia”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Liposome Drug Delivery Market Research Report

By Type

Liposomal Doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel, Others

By Application

Cancer & Tumor Therapy, Fungal Infection Therapy, Others

By Companies

Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma, Sigma-Tau Group, Fudan-Zhangjiang, Teva Pharmaceutical, CSPC, Novartis, Kingond Pharm, Spectrum Pharmaceuticals, Shanghai New Asia

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

231

Number of Tables & Figures

162

Customization Available

Yes, the report can be customized as per your need.


Global Liposome Drug Delivery Industry Outlook


Global Liposome Drug Delivery Market Report Segments:

The global Liposome Drug Delivery market is segmented on the basis of:

Types

Liposomal Doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Cancer & Tumor Therapy, Fungal Infection Therapy, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Johnson & Johnson
  2. Gilead Sciences
  3. Pacira
  4. Sun Pharmaceutical
  5. Luye Pharma
  6. Sigma-Tau Group
  7. Fudan-Zhangjiang
  8. Teva Pharmaceutical
  9. CSPC
  10. Novartis
  11. Kingond Pharm
  12. Spectrum Pharmaceuticals
  13. Shanghai New Asia

Global Liposome Drug Delivery Market Overview


Highlights of The Liposome Drug Delivery Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Liposomal Doxorubicin
    2. Liposomal Amphoteracin B
    3. Liposomal Paclitaxel
    4. Others
  1. By Application:

    1. Cancer & Tumor Therapy
    2. Fungal Infection Therapy
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Liposome Drug Delivery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Liposome Drug Delivery Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Liposomes are small, water-filled sacs that can be used to deliver drugs and other substances into the body. Liposomes are formed from a lipid (fat) molecule and a water molecule. The lipids create a bilayer around the water molecules, which allows for efficient drug delivery.

Some of the key players operating in the liposome drug delivery market are Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma, Sigma-Tau Group, Fudan-Zhangjiang, Teva Pharmaceutical, CSPC, Novartis, Kingond Pharm, Spectrum Pharmaceuticals, Shanghai New Asia.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Liposome Drug Delivery Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Liposome Drug Delivery Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Liposome Drug Delivery Market - Supply Chain
   4.5. Global Liposome Drug Delivery Market Forecast
      4.5.1. Liposome Drug Delivery Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Liposome Drug Delivery Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Liposome Drug Delivery Market Absolute $ Opportunity

5. Global Liposome Drug Delivery Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Liposome Drug Delivery Market Size and Volume Forecast by Type
      5.3.1. Liposomal Doxorubicin
      5.3.2. Liposomal Amphoteracin B
      5.3.3. Liposomal Paclitaxel
      5.3.4. Others
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Liposome Drug Delivery Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Liposome Drug Delivery Market Size and Volume Forecast by Application
      6.3.1. Cancer & Tumor Therapy
      6.3.2. Fungal Infection Therapy
      6.3.3. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Liposome Drug Delivery Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Liposome Drug Delivery Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Liposome Drug Delivery Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Liposome Drug Delivery Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Liposome Drug Delivery Demand Share Forecast, 2019-2029

9. North America Liposome Drug Delivery Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Liposome Drug Delivery Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Liposome Drug Delivery Market Size and Volume Forecast by Application
      9.4.1. Cancer & Tumor Therapy
      9.4.2. Fungal Infection Therapy
      9.4.3. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Liposome Drug Delivery Market Size and Volume Forecast by Type
      9.7.1. Liposomal Doxorubicin
      9.7.2. Liposomal Amphoteracin B
      9.7.3. Liposomal Paclitaxel
      9.7.4. Others
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Liposome Drug Delivery Demand Share Forecast, 2019-2029

10. Latin America Liposome Drug Delivery Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Liposome Drug Delivery Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Liposome Drug Delivery Market Size and Volume Forecast by Application
      10.4.1. Cancer & Tumor Therapy
      10.4.2. Fungal Infection Therapy
      10.4.3. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Liposome Drug Delivery Market Size and Volume Forecast by Type
      10.7.1. Liposomal Doxorubicin
      10.7.2. Liposomal Amphoteracin B
      10.7.3. Liposomal Paclitaxel
      10.7.4. Others
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Liposome Drug Delivery Demand Share Forecast, 2019-2029

11. Europe Liposome Drug Delivery Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Liposome Drug Delivery Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Liposome Drug Delivery Market Size and Volume Forecast by Application
      11.4.1. Cancer & Tumor Therapy
      11.4.2. Fungal Infection Therapy
      11.4.3. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Liposome Drug Delivery Market Size and Volume Forecast by Type
      11.7.1. Liposomal Doxorubicin
      11.7.2. Liposomal Amphoteracin B
      11.7.3. Liposomal Paclitaxel
      11.7.4. Others
   11.8. Basis oint Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Liposome Drug Delivery Demand Share, 2019-2029

12. Asia Pacific Liposome Drug Delivery Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Liposome Drug Delivery Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Liposome Drug Delivery Market Size and Volume Forecast by Application
      12.4.1. Cancer & Tumor Therapy
      12.4.2. Fungal Infection Therapy
      12.4.3. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Liposome Drug Delivery Market Size and Volume Forecast by Type
      12.7.1. Liposomal Doxorubicin
      12.7.2. Liposomal Amphoteracin B
      12.7.3. Liposomal Paclitaxel
      12.7.4. Others
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Liposome Drug Delivery Demand Share, 2019-2029

13. Middle East & Africa Liposome Drug Delivery Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Liposome Drug Delivery Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Liposome Drug Delivery Market Size and Volume Forecast by Application
      13.4.1. Cancer & Tumor Therapy
      13.4.2. Fungal Infection Therapy
      13.4.3. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Liposome Drug Delivery Market Size and Volume Forecast by Type
      13.7.1. Liposomal Doxorubicin
      13.7.2. Liposomal Amphoteracin B
      13.7.3. Liposomal Paclitaxel
      13.7.4. Others
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Liposome Drug Delivery Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Liposome Drug Delivery Market: Market Share Analysis
   14.2. Liposome Drug Delivery Distributors and Customers
   14.3. Liposome Drug Delivery Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Johnson & Johnson
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Gilead Sciences
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Pacira
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Sun Pharmaceutical
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Luye Pharma
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Sigma-Tau Group
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Fudan-Zhangjiang
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Teva Pharmaceutical
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. CSPC
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Novartis
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Kingond Pharm
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Spectrum Pharmaceuticals
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Shanghai New Asia
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us